
Latest content from Michael Sassano
Opinion: Where Germany’s Recreational Cannabis Plan Could Go Next
Michael Sassano, CEO of Somai Pharmaceuticals, takes a look into the future of Germany's cannabis marketplace.
VIEWMichael Sassano, CEO of Somai Pharmaceuticals, takes a look into the future of Germany's cannabis marketplace.
VIEW